First, two methods of protein detection, Western blotting and cIEF immunoassay, were deployed to profile MEK1, MEK2, and ERK1/2 proteins in total cell extracts (TCEs) of a breast cancer cell line BT474. This evidence concerns the gene MAP2K2 and breast carcinoma.